BNP Paribas Asset Management Alts

Funding rounds backed by BNP Paribas Asset Management Alts.

Export CSV
Funding disclosed in full
$175M
Median round
$87.5M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Vedanta Biosciences

Develops microbiome-based oral therapies for prevention of recurrent C. difficile infection

$60MGrowthBiotechUnited States
3 participantsAMR Action FundBARDABNP Paribas Asset Management Alts
ILiAD Biotechnologies

Developing a next-generation pertussis vaccine candidate BPZE1

$115MSeries BBiotechUnited States
4 participantsAI Life SciencesBNP Paribas Asset Management AltsJanus Henderson InvestorsRA Capital Management